Editorial: Immune-related adverse events for patients with lung cancer-volume II

Affiliations

Yusha Wang: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
Xia Wang: Department of Biotherapy Research, West China Hospital, Sichuan University, Chengdu, Sichuan, China
Cheng Zhan: Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
Benjamin Frey: Department of Radiation Oncology, Universitätsklinikum Erlangen, Erlangen, Germany
Udo S. Gaipl: Department of Radiation Oncology, Universitätsklinikum Erlangen, Erlangen, Germany
Hubing Shi: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
Xuelei Ma: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China

Abstract

No abstracts available.

ISSN: 2234-943X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.frontiersin.org/journals/oncology/